GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
D

Dr. Lal PathLabs LALPATHLAB.NS · INR

Health Care · NSE · 🇮🇳 India

Compare

2,016.50

+2.36%

Close of 9 Nov 2026, in INR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in INR, from our data supplier.

FY2026

Revenue

₹27.63bn

FY2017FY2026

Net income

₹5.05bn

FY2017FY2026

Free cash flow

₹5.35bn

FY2017FY2026

Shareholders' equity

₹25.08bn

FY2017FY2026

Income statement

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue₹27.63bn₹24.61bn₹22.27bn₹20.17bn₹20.87bn₹15.81bn₹13.30bn₹12.03bn₹10.57bn₹9.12bn
Research and development——₹38.8m₹36.0m₹33.9m—————
Operating income₹6.21bn₹6.47bn₹5.35bn₹3.51bn₹7.37bn₹4.10bn₹4.45bn₹4.13bn₹3.63bn₹3.15bn
Net income₹5.05bn₹4.87bn₹3.58bn₹2.39bn₹3.45bn₹2.92bn₹2.26bn₹1.99bn₹1.71bn₹1.55bn
Diluted earnings per share30.1729.1221.4214.3420.7317.5613.6412.0610.349.45

Balance sheet

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Total assets₹31.46bn₹27.17bn₹24.56bn₹23.86bn₹23.53bn₹16.61bn₹13.74bn₹10.90bn₹9.19bn₹7.64bn
Cash and short-term investments₹13.32bn₹11.65bn₹9.43bn₹8.51bn₹6.82bn₹9.84bn₹7.32bn₹6.74bn₹4.55bn₹3.43bn
Total liabilities₹6.05bn₹5.10bn₹5.71bn₹6.86bn₹8.10bn₹3.85bn₹3.20bn₹1.40bn₹1.24bn₹1.02bn
Debt₹1.99bn₹1.57bn₹2.47bn₹4.20bn₹5.33bn₹1.50bn₹1.29bn₹1.29bn₹62.3m₹37.3m
Shareholders' equity₹25.08bn₹21.73bn₹18.49bn₹16.66bn₹15.08bn₹12.45bn₹10.33bn₹9.45bn₹7.91bn₹6.60bn
Shares outstanding167m167m167m167m166m166m166m165m165m164m

Cash flow

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations₹7.02bn₹5.69bn₹5.35bn₹4.56bn₹4.47bn₹3.98bn₹2.84bn₹2.19bn₹1.97bn₹1.72bn
Capital spending−₹1.67bn−₹443.0m−₹511.7m−₹446.0m−₹4.76bn−₹595.9m−₹796.2m−₹420.4m−₹724.7m−₹515.9m
Free cash flow₹5.35bn₹5.25bn₹4.84bn₹4.11bn−₹294.5m₹3.39bn₹2.04bn₹1.76bn₹1.25bn₹1.20bn
Dividends paid−₹2.23bn−₹2.07bn−₹2.01bn−₹1.03bn−₹1.17bn−₹994.8m−₹1.56bn−₹551.9m−₹318.4m−₹378.0m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue₹7.98bn₹7.03bn₹6.60bn₹7.31bn₹6.70bn₹6.02bn₹5.97bn₹6.60bn
Operating income₹2.03bn₹1.42bn₹1.37bn₹1.84bn₹1.86bn₹1.59bn₹1.44bn₹1.89bn
Net income₹1.70bn₹1.31bn₹905.0m₹1.51bn₹1.32bn₹1.55bn₹967.0m₹1.29bn
Diluted earnings per share10.137.855.419.007.919.265.797.74
Cash from operations———₹3.24bn—₹5.69bn—₹3.07bn
Capital spending———−₹1.34bn—−₹538.0m—−₹156.0m
Free cash flow———₹1.90bn—₹5.15bn—₹2.91bn
Total assets—₹31.46bn—₹29.59bn—₹27.17bn—₹25.98bn
Cash and short-term investments₹13.31bn₹13.32bn₹13.02bn₹13.02bn₹11.64bn₹11.65bn₹11.27bn₹11.27bn
Debt—₹536.0m—₹1.56bn—₹1.57bn—₹1.99bn
Shareholders' equity₹25.41bn₹25.08bn₹24.22bn₹23.88bn₹22.06bn₹21.73bn₹20.35bn₹20.02bn

Growth per year

Compound annual rate

3 years5 years10 years
Revenue11.1%11.8%13.3%
Operating income20.9%8.6%13.0%
Net income28.3%11.6%14.3%

Average margins

Over each period

1 year3 years5 years10 years
Operating margin24.3%22.8%25.1%27.2%
Net margin19.0%16.8%16.9%16.9%

Valuation history

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Price to earnings67.050.969.690.054.5108.784.462.044.046.7
Price to sales12.210.111.210.79.020.014.310.37.17.9

Dividends and splits

Per share, in the currency the company pays

Paid for 10 years. Last went ex-dividend on 30 Jul 2026.

FY2027FY2026FY2025FY2024FY2023FY2022FY2021FY2020
Paid in the year9.0013.0012.0012.006.007.006.007.75
  • 2-for-1 split · 19 Dec 2025

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.